阿尔尼拉姆制药公司宣布获得加拿大卫生部门对Amvuttra®(Vutrisiran)的批准,这是首个也是唯一用于治疗成年人ATTR淀粉样变性心肌病的RNAi疗法

美股速递
Dec 16, 2025

阿尔尼拉姆制药公司宣布获得加拿大卫生部门对Amvuttra®(Vutrisiran)的批准,这是首个也是唯一用于治疗成年患者ATTR淀粉样变性心肌病的RNAi疗法。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10